
NeuroMetrix NURO
Annual report 2024
added 03-31-2025
NeuroMetrix DPO Ratio 2011-2026 | NURO
Annual DPO Ratio NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.1 | 54.5 | 47.5 | 33.4 | 24.4 | 37.7 | 54.4 | 26.1 | 37.7 | 97.9 | 74.3 | 53.7 | 26.2 | 48.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 97.9 | 24.4 | 49.6 |
Quarterly DPO Ratio NeuroMetrix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 | 75.5 | 28.5 | - | 44.1 | 49.5 | 66.6 | - | 61.8 | 50.6 | 57.8 | - | 44.7 | 46.9 | 33.8 | - | 24.2 | 26.2 | 63.9 | - | 72.4 | 21.1 | 39.7 | - | 65 | 60.7 | 31.4 | - | 32.8 | 25.4 | 24.8 | - | 33 | 42.6 | 55.2 | - | 86.4 | 163 | 113 | - | 74.7 | 72.8 | 62.7 | - | 50.9 | 58.8 | 46.5 | - | 50 | 40.1 | 41.4 | - | 49.7 | 51.7 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 163 | 21.1 | 54.9 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
72.6 | $ 70.29 | 0.17 % | $ 14 B | ||
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
63.6 | $ 74.63 | 0.09 % | $ 40.4 B | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Baxter International
BAX
|
45.6 | $ 16.65 | -0.18 % | $ 8.54 B | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
BioLife Solutions
BLFS
|
130 | $ 19.27 | -1.23 % | $ 888 M | ||
|
AtriCure
ATRC
|
68.7 | $ 29.19 | 0.41 % | $ 1.39 B | ||
|
electroCore
ECOR
|
195 | $ 7.04 | 3.53 % | $ 59.7 K | ||
|
Ekso Bionics Holdings
EKSO
|
91.4 | $ 9.75 | 3.72 % | $ 23.7 M | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 116.69 | 3.48 % | $ 5.65 B | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 58.46 | 2.87 % | $ 2.94 B | ||
|
Harvard Bioscience
HBIO
|
42 | $ 5.53 | 6.35 % | $ 245 M | ||
|
ICU Medical
ICUI
|
39.2 | $ 122.99 | -0.26 % | $ 3.03 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 9.43 | 1.51 % | $ 195 M | ||
|
iRhythm Technologies
IRTC
|
7.87 | $ 117.22 | 0.36 % | $ 3.75 B | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
23.9 | $ 452.58 | 0.11 % | $ 162 B | ||
|
Repro Med Systems
KRMD
|
46.1 | $ 4.26 | -1.39 % | $ 197 M | ||
|
LeMaitre Vascular
LMAT
|
13.9 | $ 109.16 | 0.62 % | $ 2.47 B | ||
|
Masimo Corporation
MASI
|
84.4 | $ 178.49 | -0.06 % | $ 9.51 B | ||
|
Microbot Medical
MBOT
|
52.9 | $ 2.36 | -1.67 % | $ 108 M | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.29 | 1.9 % | $ 23.8 M | ||
|
Merit Medical Systems
MMSI
|
30.3 | $ 67.81 | 0.16 % | $ 4.01 B | ||
|
Envista Holdings Corporation
NVST
|
54.2 | $ 25.81 | - | $ 4.34 B | ||
|
Predictive Oncology
POAI
|
7.25 K | - | - | $ 31.1 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 48.53 | -6.08 % | $ 160 M | ||
|
Pulse Biosciences
PLSE
|
1.51 K | $ 22.94 | -0.26 % | $ 1.55 B | ||
|
ResMed
RMD
|
34.9 | $ 224.93 | 0.37 % | $ 32.9 B | ||
|
Retractable Technologies
RVP
|
46 | $ 0.71 | 2.98 % | $ 21.3 M | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 20.96 | 3.71 % | $ 1.04 B | ||
|
STERIS plc
STE
|
31.8 | $ 219.97 | 0.58 % | $ 21.7 B | ||
|
Stereotaxis
STXS
|
124 | $ 1.88 | -0.53 % | $ 171 M | ||
|
Teleflex Incorporated
TFX
|
47.7 | $ 115.04 | -2.35 % | $ 5.13 B | ||
|
Utah Medical Products
UTMD
|
17.8 | $ 62.93 | -0.3 % | $ 204 M | ||
|
West Pharmaceutical Services
WST
|
45.7 | $ 256.85 | 0.8 % | $ 18.6 B | ||
|
DENTSPLY SIRONA
XRAY
|
53.7 | $ 11.64 | 0.09 % | $ 2.32 B | ||
|
AngioDynamics
ANGO
|
96.2 | $ 9.84 | -4.56 % | $ 402 M | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 155.32 | 0.52 % | $ 44.7 B | ||
|
Nephros
NEPH
|
50.5 | $ 2.86 | -0.35 % | $ 29.7 M | ||
|
OraSure Technologies
OSUR
|
40.1 | $ 3.08 | - | $ 226 M | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 116.95 | -0.7 % | $ 6.52 M |